Wednesday, January 2, 2013

Kidney International Supplements - Table of Contents alert Volume 3 Issue 1

KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease


KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines.

TABLE OF CONTENTS

Volume 3, Issue 1 (January 2013)

In this issue
Preface
Contents
Appendix


Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
 

Preface

Top

Notice

Kidney inter., Suppl. 2013 3: 1; 10.1038/kisup.2012.73

Full Text | PDF

Foreword

Kidney inter., Suppl. 2013 3: 2; 10.1038/kisup.2012.74

Full Text | PDF

Work Group Membership

Kidney inter., Suppl. 2013 3: 3; 10.1038/kisup.2012.75

Full Text | PDF

Abstract

Kidney inter., Suppl. 2013 3: 4; 10.1038/kisup.2012.76

Full Text | PDF

Summary of Recommendation Statements

Kidney inter., Suppl. 2013 3: 5-14; 10.1038/kisup.2012.77

Full Text | PDF

Introduction: The case for updating and context

Kidney inter., Suppl. 2013 3: 15-18; 10.1038/kisup.2012.63

Full Text | PDF

Contents

Top

Chapter 1: Definition and classification of CKD

Kidney inter., Suppl. 2013 3: 19-62; 10.1038/kisup.2012.64

Full Text | PDF

Chapter 2: Definition, identification, and prediction of CKD progression

Kidney inter., Suppl. 2013 3: 63-72; 10.1038/kisup.2012.65

Full Text | PDF

Chapter 3: Management of progression and complications of CKD

Kidney inter., Suppl. 2013 3: 73-90; 10.1038/kisup.2012.66

Full Text | PDF

Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD

Kidney inter., Suppl. 2013 3: 91-111; 10.1038/kisup.2012.67

Full Text | PDF

Chapter 5: Referral to specialists and models of care

Kidney inter., Suppl. 2013 3: 112-119; 10.1038/kisup.2012.68

Full Text | PDF

Appendix

Top

Methods for guideline development

Kidney inter., Suppl. 2013 3: 120-127; 10.1038/kisup.2012.69

Full Text | PDF

Biographic and Disclosure Information

Kidney inter., Suppl. 2013 3: 128-133; 10.1038/kisup.2012.70

Full Text | PDF

Acknowledgments

Kidney inter., Suppl. 2013 3: 134-135; 10.1038/kisup.2012.71

Full Text | PDF

References

Kidney inter., Suppl. 2013 3: 136-150; 10.1038/kisup.2012.72

Full Text | PDF

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International Supplements. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: